Cargando…
Severe Hypocalcemia due to Denosumab in Metastatic Prostate Cancer
Denosumab is a monoclonal antibody used for prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors. Hypocalcemia is a rare and dangerous side effect of the drug Denosumab. We present a case of a patient with metastatic prostate cancer who developed severe hyp...
Autores principales: | Muqeet Adnan, Mohammed, Bhutta, Usman, Iqbal, Tanzeel, AbdulMujeeb, Sufyan, Haragsim, Lukas, Amer, Syed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099037/ https://www.ncbi.nlm.nih.gov/pubmed/25054070 http://dx.doi.org/10.1155/2014/565393 |
Ejemplares similares
-
Black Cohosh and Liver Toxicity: Is There a Relationship?
por: Muqeet Adnan, Mohammed, et al.
Publicado: (2014) -
Denosumab Induced Severe Prolonged Hypocalcemia in Metastatic Prostate Cancer
por: Mehmood, Hassan, et al.
Publicado: (2021) -
Hypocalcemia in a Patient With Metastatic Prostate Cancer From Denosumab Treatment
por: Gouli, Sugam, et al.
Publicado: (2021) -
Denosumab Induced Severe Hypocalcemia in a Patient With Metastatic Prostate Cancer
por: Naher, Kamrun, et al.
Publicado: (2021) -
Diagnosis and Management of Denosumab-Induced Hypocalcemia and Hypophosphatemia in the Setting of Metastatic Prostate Cancer
por: Flood, Michael G, et al.
Publicado: (2022)